2021-01-04 09:16:12 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/745764e250343935ede96c7044830b1a |
Change of Director's Interest Notice
|
2021-01-04 16:32:25 |
Resignation and Appointment of Joint Company Secretary |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d8c5bf92b18678789fa4c3486951db82 |
Company Secretary Appointment/Resignation
|
2021-01-07 09:33:30 |
Recruitment of head & neck cancer patients completed for ph2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b282f0aa912f4eba67e545561e46fe27 |
|
2021-01-22 08:54:41 |
Ulcerative Colitis Phase II Study of GSK2831781 Discontinued |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b49361c2e4d8ba470d13bbe9fa49688d |
|
2021-01-22 08:57:44 |
Immutep Quarterly Activities Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/134e88f9e15ce676a5042cb5cf1a075d |
Commitments Test Entity - Second Quarter Report
Commitments Test Entity - Second Quarter Activity Report
|
2021-01-27 08:59:55 |
Phase II study for eftilagimod alpha in COVID-19 advances |
1 |
https://app.sharelinktechnologies.com/announcement/asx/664902db7240bb7cba5c66d7b3423171 |
|
2021-02-02 08:22:38 |
Immutep Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/582866b95d1c209f5b4f6d1c7e5f1de3 |
|
2021-02-23 16:23:10 |
Half Yearly Report and Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/2c9b08f6edafcf14750d2c177dcf3351 |
Half Year Directors' Statement
Half Year Directors' Report
|
2021-03-05 08:21:59 |
Immutep expands Part B of TACTI-002 collaboration trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/bbb1d7514ab72d46e000dcee74501110 |
|
2021-03-09 16:14:10 |
Immutep secures second US patent grant for eftilagimod alpha |
1 |
https://app.sharelinktechnologies.com/announcement/asx/41f6b9048f935597ea6e893eff2f0ca2 |
|
2021-03-12 17:02:21 |
S&P DJI Announces March 2021 Quarterly Rebalance |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c4537e50aec7075a471239bf8c2eda5b |
Standard and Poor's Announcement
|
2021-03-16 08:17:04 |
Immutep collaborates with MSD for phase 2b head & neck trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/7643ce43da10739415e60b72c6637357 |
|
2021-03-18 10:59:54 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/73059327bf6361943da9adde0989e2ca |
Appendix 2A (Application for Quotation of Securities
|
2021-04-01 08:22:42 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/385257157ffb8eb99ad6db3df55a79f6 |
Change in substantial holding
|
2021-04-07 08:28:20 |
Immutep announces European Patent Grant for LAG525 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/39a5bf1b616c166cad4fb356fb62458f |
|
2021-04-08 07:52:50 |
Immutep achieves Fast Track designation for Efti from US FDA |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a7e3d93fdbadd8d404a04d98ae1a9102 |
|
2021-04-14 09:25:22 |
Immutep Investor Update |
0 |
https://app.sharelinktechnologies.com/announcement/asx/eb22db530362edbf05a023e891d31bd6 |
|
2021-04-16 17:46:16 |
Immutep receives A$1,155,055 R&D Tax Incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f58f0089b468a9eeb40e7d741b629853 |
|
2021-04-19 09:40:35 |
Immutep Quarterly Activities Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0c7a329b28494d856af0df7495318cc3 |
Commitments Test Entity - Third Quarter Report
Commitments Test Entity - Third Quarter Activity Report
|
2021-04-29 07:31:00 |
TACTI-002 & INSIGHT-004 data to be presented at ASCO |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0fbcf95f9d00a58dbfe5737ae93ebf8d |
|
2021-05-07 09:49:44 |
Operational Update |
1 |
https://app.sharelinktechnologies.com/announcement/asx/65107ca1c65ece41c5091bc4c7e527af |
|
2021-05-13 11:51:43 |
Immutep Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b11fba3d9bac3dcef04ce7b0c4b7bd81 |
|
2021-05-14 10:55:50 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7fb4ed5ef6cb4aab03bcb32ac19d14dc |
Appendix 2A (Application for Quotation of Securities
|
2021-05-18 08:20:06 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8b3f3a2d6233ca833f44e3da4fd9c7c1 |
Change in substantial holding
|
2021-05-20 08:22:26 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ff4afb46385008c041a9b8b405c4a5d0 |
Change in substantial holding
|
2021-05-20 13:07:02 |
TACTI-002 and INSIGHT-004 abstracts for ASCO 2021 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bef8c6c7c58dacf7c66883287f0d7c21 |
|
2021-05-25 08:16:08 |
Immutep to present at Jefferies Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/605d69ed40c022f99950f4e6fa278491 |
|
2021-05-26 13:32:27 |
Immutep granted Chinese patent for its LAG-3 candidate Efti |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5c1429f315dc3790d185d8b2283184f6 |
|
2021-06-01 08:20:54 |
Immutep enters New Collaboration with Merck KGaA for Efti |
1 |
https://app.sharelinktechnologies.com/announcement/asx/11a993942460c351e34f2d6feb4af49b |
|
2021-06-02 11:13:08 |
Immutep granted European patent for its LAG-3 candidate Efti |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e90b85fa55acf843846b49cce6ffcf0f |
|
2021-06-04 16:14:12 |
Immutep Reports Positive Final Data from INSIGHT-004 trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/5637138be503b944b141e6ce009cf008 |
|
2021-06-04 16:17:14 |
Immutep Reports Positive Data from its TACTI-002 ph 2 trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/08fcddd4325d30cccf9d542c4c58655f |
|
2021-06-04 16:19:17 |
Immutep presentation for Jefferies Healthcare Conference |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8701ce847fe4795edca20698d8425f9a |
|
2021-06-07 16:01:01 |
Application for quotation of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b0b347467f1c67446c218755eaf2e112 |
Appendix 2A (Application for Quotation of Securities
|
2021-06-08 07:37:31 |
Immutep Reveals a New anti-LAG-3 Research Program |
1 |
https://app.sharelinktechnologies.com/announcement/asx/99e8bedefdaa831eb19915a6b3281903 |
|
2021-06-08 16:11:08 |
Appendix 2A |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ecad5c766040f0d922e86cd5af3235a5 |
Appendix 2A (Application for Quotation of Securities
|
2021-06-09 19:21:17 |
Immutep global webcast slides |
1 |
https://app.sharelinktechnologies.com/announcement/asx/f9b7f433005f5f54b0a5ab7912883edb |
|
2021-06-15 08:17:35 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/8e5592a98ea23511fcb7184e69ebf3ca |
Change in substantial holding
|
2021-06-17 08:20:10 |
Trading Halt |
1 |
https://app.sharelinktechnologies.com/announcement/asx/41936ead4cd5a523509d3eafb78fad91 |
|
2021-06-21 09:47:05 |
Immutep Capital Raising Presentation |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3b8f689fc06fcbb5015f353dfb9806aa |
|
2021-06-21 09:47:36 |
Immutep secures commitments for A$60 million in a Placement |
1 |
https://app.sharelinktechnologies.com/announcement/asx/a19a324728fe82f5d6036ddefbdb5715 |
Company Administration - Other
|
2021-06-21 09:48:00 |
Proposed issue of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/590386b1585cfd8efe4ee8506973d218 |
|
2021-06-21 09:48:16 |
Efti to be evaluated in new triple combination therapy trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/944de89bb3de4a254cc1f87076ad370c |
|
2021-06-25 11:39:37 |
Application for quotation of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b9e13bbb4fa49f71df87e24bf837af56 |
Appendix 2A (Application for Quotation of Securities
|
2021-06-25 16:04:57 |
Share Purchase Plan Offer Documents |
0 |
https://app.sharelinktechnologies.com/announcement/asx/df23b9bcb2f8c5b1b0a31e14eff41c7c |
|
2021-06-25 16:15:03 |
Notice of Extraordinary General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/9d5d343faa5eb2761f66006ae297d60b |
Notice of Extraordinary General Meeting
|
2021-06-28 08:11:08 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/219dcbf79a2dc532609951f56fb117c4 |
|
2021-06-30 08:19:57 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/55f99639fe98995325ac2daeb882cf34 |
Ceasing to be a substantial holder
|
2021-06-30 12:28:26 |
Change in substantial holding from AEF |
0 |
https://app.sharelinktechnologies.com/announcement/asx/61a5614e8a30da23b962b4b2c91d6e87 |
Change in substantial holding
|
2021-07-05 16:34:32 |
Proposed issue of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7872159a956938d7d471562ffb7c171b |
|
2021-07-06 08:58:53 |
US FDA & IRB approves start of ph2b head & neck cancer trial |
1 |
https://app.sharelinktechnologies.com/announcement/asx/0b9d71777ef1bd3cbd33a70ee3aef1c2 |
|
2021-07-13 09:48:42 |
Immutep Quarterly Activities Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c1742ebd49f96db1399ca9641226d13e |
Commitments Test Entity - Fourth Quarter Report
Commitments Test Entity - Fourth Quarter Activity Report
|
2021-07-15 13:10:07 |
EGM - Now to be Held as an Online Virtual Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/a36435de51c81afc7d92212918106c77 |
Notice of Meeting - Other
|
2021-07-21 09:00:37 |
Completion of Share Purchase Plan |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d55a0c77b19929af14b4239f6b75b11a |
|
2021-07-23 08:25:09 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d1fc971a2866361ec311f5aa157aa650 |
Change in substantial holding
|
2021-07-23 08:25:28 |
Application for quotation of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0a1ccb4455027c2ec08a701650d9af65 |
Appendix 2A (Application for Quotation of Securities
|
2021-07-26 11:56:46 |
2021 EGM Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f10312319d80acbce69c18ecfd259d44 |
|
2021-07-26 12:04:58 |
Chairman's EGM Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d560eaa15d64f0d5f07dfcf637e686b5 |
Chairman's Address to Shareholders
|
2021-07-26 18:37:34 |
Results of EGM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b928c3771ba7ce5d2ae41f37c1e7f38b |
|
2021-07-27 08:15:32 |
Proposed issue of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/da000531257c421e2801e91309b5eee8 |
|
2021-07-27 08:19:01 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/225ff93f0931bddc2021042e7ec46e6d |
Change in substantial holding
|
2021-07-29 08:22:53 |
Application for quotation of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/bc65adefe6e522d5efe382b9a0b7ec57 |
Appendix 2A (Application for Quotation of Securities
|
2021-07-30 09:24:08 |
Completion of Placement - Tranche 2 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d14e7c81279f79065a955a473fd062ec |
|
2021-07-30 10:03:00 |
Cleansing Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/926f48d93f7fda9edcad84be555e7ca6 |
|
2021-08-03 08:21:13 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/ca6dc040baa03420b9619e75b58d547b |
Change in substantial holding
|
2021-08-03 19:18:16 |
Becoming a substantial holder |
0 |
https://app.sharelinktechnologies.com/announcement/asx/4bc0db212051d228aeb70df0808bc605 |
Becoming a substantial holder
|
2021-08-05 08:18:42 |
INSIGHT-003 investigator-initiated trial - 1st patient dosed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/6cead79bcb3c82fde88d5f347d415107 |
|
2021-08-27 08:04:41 |
Chinese patent granted for anti-LAG-3 antibody LAG525 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ed73b96655191eb3ebc84098357a844f |
|
2021-08-30 19:08:57 |
Appendix 4E & 2021 Full Year Statutory Accounts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/86dbf512036b38e34ff51d1b390db197 |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-08-31 08:46:35 |
Immutep's partner, EOC Pharma, expands efti trial pipeline |
1 |
https://app.sharelinktechnologies.com/announcement/asx/1311bd70fafe93f8a246910e17c235ee |
|
2021-09-01 10:07:01 |
Recruitment of patients completed for Part B of TACTI-002 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/c67d3418fb751a5fa7577505cb8c91b1 |
|
2021-09-21 18:38:31 |
Immutep to present final AIPAC Overall Survival data at SITC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/5156847da7a212d1a9de72f125c39e29 |
Company Administration - Other
|
2021-09-27 18:37:30 |
Immutep Corporate Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b6154f501fe21cfdd17b7fc80d19143b |
|
2021-09-28 12:09:05 |
Immutep to Present at Healthcare Investor Conferences |
0 |
https://app.sharelinktechnologies.com/announcement/asx/774a4d56eb2f56ccfeaa1e37ef5e464d |
|
2021-09-29 08:47:40 |
Immutep Receives A$3.4 million R&D French Tax Incentive |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e99859ed8d6f1d1986dbeb05bfe5f9c9 |
Company Administration - Other
|
2021-10-01 11:55:52 |
Application for quotation of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6cfea084902d5c66a2ea4dbc313eb6e4 |
Appendix 2A (Application for Quotation of Securities
|
2021-10-01 16:16:12 |
Notification regarding unquoted securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/991ca2dd442f81448e391b132ec3e36d |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-10-04 08:24:45 |
Immutep to present Phase II TACTI-002 data at SITC 2021 |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3c075f3eb1be075178cff9a3ad69405e |
|
2021-10-04 09:25:23 |
Change of Director's Interest Notice - Mr Meyers |
0 |
https://app.sharelinktechnologies.com/announcement/asx/cfbcb7d8a4fd5eb695e33b1671e68707 |
Change of Director's Interest Notice
|
2021-10-04 09:27:25 |
Change of Director's Interest Notice - Mr Chamberlain |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3369f3c41c53303c5f96f4ecbc17596e |
Change of Director's Interest Notice
|
2021-10-07 08:46:42 |
Ceasing to be a substantial holder from AEF |
0 |
https://app.sharelinktechnologies.com/announcement/asx/0ce4ad84fd3333f1204b5785fe2bb2e0 |
Ceasing to be a substantial holder
|
2021-10-12 19:03:58 |
2021 AGM & Key Dates |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c83c36b48c4350fdee205cb15fa3ca66 |
Notice of Meeting - Other
|
2021-10-26 09:05:57 |
Annual Report filed on Form 20-F with SEC |
0 |
https://app.sharelinktechnologies.com/announcement/asx/891c87830897ce4d5c969a183540a428 |
|
2021-10-26 09:14:08 |
Annual Report to shareholders |
0 |
https://app.sharelinktechnologies.com/announcement/asx/06713e913038d3cf46e27aa7bc95a99e |
Full Year Directors' Statement
Full Year Directors' Report
|
2021-10-26 09:39:28 |
Appendix 4G |
0 |
https://app.sharelinktechnologies.com/announcement/asx/763775cf42cedaa11b603cf08c108d9f |
|
2021-10-26 10:35:19 |
Notice of Annual General Meeting/Proxy Form |
0 |
https://app.sharelinktechnologies.com/announcement/asx/6f48101f02d6674a56f47cb8804d76e3 |
Notice of Annual General Meeting
|
2021-10-28 08:30:23 |
Immutep Quarterly Activities Report & Appendix 4C |
1 |
https://app.sharelinktechnologies.com/announcement/asx/855fce1e934f3c0385997495db732dae |
Commitments Test Entity - First Quarter Report
Commitments Test Entity - First Quarter Activity Report
|
2021-10-29 08:19:30 |
Immutep receives EMA scientific advice for Phase 3 in MBC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/ca244b6daefe038f50d8411b5d6e33a8 |
Company Administration - Other
|
2021-11-02 10:57:53 |
Immutep granted Chinese Patent for eftilagimod alpha |
1 |
https://app.sharelinktechnologies.com/announcement/asx/d6654fa7dbb3580ce94afb08c97e4429 |
|
2021-11-08 16:18:15 |
JobKeeper Payment Notice |
0 |
https://app.sharelinktechnologies.com/announcement/asx/b8aad393fc0a75dcf0b503fc3b4cba5f |
|
2021-11-10 08:24:15 |
Final Phase IIb AIPAC clinical trial results for Efti in MBC |
1 |
https://app.sharelinktechnologies.com/announcement/asx/b53092617dbfa6d862ec000ef13df73f |
|
2021-11-10 08:24:28 |
Immutep announces publication of SITC 2021 abstracts |
1 |
https://app.sharelinktechnologies.com/announcement/asx/684d9f6ae38f620630aedc945a0b08aa |
Company Administration - Other
|
2021-11-15 08:37:38 |
Chinese Patent Granted for Efti with PD-1 Pathway Inhibitors |
1 |
https://app.sharelinktechnologies.com/announcement/asx/3090f8a5cac202c64488a0890c4d65a6 |
|
2021-11-15 08:37:44 |
Immutep announces publication of SITC 2021 posters |
1 |
https://app.sharelinktechnologies.com/announcement/asx/e251b3b86c5dd8b811c47b44abddccba |
|
2021-11-16 18:19:15 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/96153bffcddaa46a61baaab412e8f7b9 |
Change in substantial holding
|
2021-11-17 07:30:01 |
Immutep Global Webcast Slides to Discuss Clinical Results |
1 |
https://app.sharelinktechnologies.com/announcement/asx/197511d1eae1c986a4f919e533259060 |
|
2021-11-17 08:17:14 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f13ec698c2dd728de6589a1c1e35c25c |
Change in substantial holding
|
2021-11-19 08:30:23 |
Phase II TACTI-002 trial recruitment successfully completed |
1 |
https://app.sharelinktechnologies.com/announcement/asx/fc72d114de30e049da50e3054ad4c3a0 |
|
2021-11-26 08:16:32 |
Immutep AGM 2021 - Chairman's Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/212adc0869702b1df7c9cddea9d7e6ed |
Chairman's Address to Shareholders
|
2021-11-26 08:17:36 |
Immutep AGM 2021 - CEO's Presentation |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d7cd08eb52aa9ca1a906cd8b18ed14da |
Chairman's Address to Shareholders
|
2021-11-26 12:35:31 |
Results of Meeting |
0 |
https://app.sharelinktechnologies.com/announcement/asx/e8e6b723bd8237bb629ba987ae25b92b |
|
2021-11-30 14:15:13 |
Notification regarding unquoted securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/c98734468564b37ba1b1157cbe6a3648 |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-11-30 14:26:25 |
Proposed issue of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/59bd1164d7bcd45f25fae73f8484e803 |
|
2021-12-01 17:27:25 |
Application for quotation of securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/3f6b7296b0e86c88dea0a20b6509a32d |
Appendix 2A (Application for Quotation of Securities
|
2021-12-01 17:44:42 |
Change of Director's Interest Notice - Mr Voigt |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f825777804a92c2bd8dbf272d2c22a82 |
Change of Director's Interest Notice
|
2021-12-01 17:46:44 |
Change of Director's Interest Notice - Dr. Howard |
0 |
https://app.sharelinktechnologies.com/announcement/asx/f1815d607d71d2288f30094edbfcfc9b |
Change of Director's Interest Notice
|
2021-12-02 08:22:43 |
Good safety reported from 1st five patients in INSIGHT-003 |
1 |
https://app.sharelinktechnologies.com/announcement/asx/278faf2976f68418b87ab5936e881556 |
|
2021-12-02 19:41:39 |
Notification regarding unquoted securities - IMM |
0 |
https://app.sharelinktechnologies.com/announcement/asx/7405ee816f92aab7ced121588aab5f6b |
Appendix 3G (Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
|
2021-12-06 08:22:05 |
Change in substantial holding |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d2865d515a3aa7c6994a6ae07a86737f |
Change in substantial holding
|
2021-12-14 16:10:08 |
Amended Constitution |
0 |
https://app.sharelinktechnologies.com/announcement/asx/d322b7f2f1078e2cdb5ca0586aac9d2c |
|
2021-12-14 16:14:12 |
Change of Registered Office Address |
0 |
https://app.sharelinktechnologies.com/announcement/asx/1aff9c0d4f9a45dedabde63328e3013f |
Details of Company Address
Details of Registered office address
|
2021-12-16 08:20:51 |
Immutep Advances IMP761 Manufacturing |
1 |
https://app.sharelinktechnologies.com/announcement/asx/82fcbe1c20c94827f4d4e8d93dcb7cdc |
|